Loading clinical trials...

A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer | Clinical Trials | Clareo Health

COMPLETEDNA

A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer

Diagnostic Values of Probe-based Confocal Laser Endomicroscopy (pCLE) and Magnifying Narrow Band Imaging (M-NBI) for Early Neoplasms Detection in Esophageal Lugol'S-voiding Lesions.

NCT02182804•King Chulalongkorn Memorial Hospital

View on ClinicalTrials.gov

Summary

This descriptive cross sectional study aims to directly compare the diagnostic capability of the probed-based confocal laser endomicroscopy (pCLE) and the magnifying narrow band imaging (M-NBI) in the Lugol's voiding lesions.

Eligibility

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age over 20 years
•Having histological-confirmed diagnosis of head and neck cancer
•Having no esophageal symptoms

Exclusion Criteria

•Having index cancer of nasopharynx
•History of esophageal surgery
•Having esophageal stricture or obstruction
•Having esophageal varices
•Known case of esophageal cancer
•Uncorrectable coagulopathy and thrombocytopenia
•Pregnancy
•Thyrotoxicosis
•Creatinine clearance less than 30 ml/min
•Allergy to iodine or fluorescein.

Key Dates

Start Date

February 1, 2013

Primary Completion Date

June 1, 2014

Completion Date

June 1, 2014

Last Updated

August 28, 2020

Enrollment

ACTUAL participants

Conditions

Esophageal Neoplasms

Interventions

Olympus

DEVICE

Cellvizio

DEVICE

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

NCT07035587

Lung NeoplasmsPancreatic Neoplasms+6 more

View study

RECRUITING

Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers

NCT05688176

Esophageal Neoplasms

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer

Inclusion Criteria

Exclusion Criteria

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Esophageal Cancer Multimodal Prehabilitation Study

A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma

KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)